TRXADE HEALTH INC (MEDS) Stock Price, Quote, News and Overview

What is the stock price of TRXADE HEALTH INC today?

The current stock price of MEDS is 7.59 USD. The price increased by 4.83% in the last trading session.

What is the ticker symbol for TRXADE HEALTH INC stock?

The exchange symbol of TRXADE HEALTH INC is MEDS and it is listed on the Nasdaq exchange.

On which exchange is MEDS stock listed?

MEDS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for TRXADE HEALTH INC stock?

7 analysts have analysed MEDS and the average price target is 6.89 USD. This implies a price decrease of -9.29% is expected in the next year compared to the current price of 7.59. Check the TRXADE HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is TRXADE HEALTH INC worth?

TRXADE HEALTH INC (MEDS) has a market capitalization of 11.08M USD. This makes MEDS a Nano Cap stock.

How many employees does TRXADE HEALTH INC have?

TRXADE HEALTH INC (MEDS) currently has 8 employees.

What are the support and resistance levels for TRXADE HEALTH INC (MEDS) stock?

TRXADE HEALTH INC (MEDS) has a support level at 6.59 and a resistance level at 9.96. Check the full technical report for a detailed analysis of MEDS support and resistance levels.

Is TRXADE HEALTH INC (MEDS) expected to grow?

The Revenue of TRXADE HEALTH INC (MEDS) is expected to grow by 4.1% in the next year. Check the estimates tab for more information on the MEDS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy TRXADE HEALTH INC (MEDS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of MEDS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of MEDS, evaluating the profitability, health, valuation and growth aspects
• TRXADE HEALTH INC (MEDS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• TRXADE HEALTH INC (MEDS) Sales and EPS estimates to see what analysts future expectations are.
• TRXADE HEALTH INC (MEDS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• TRXADE HEALTH INC (MEDS) Insider and Institutional Ownership to learn about the owners and their transactions.
• TRXADE HEALTH INC (MEDS) Stock Chart to make your own analysis
• TRXADE HEALTH INC (MEDS) Latest news and press-releases to stay up to date.

Does TRXADE HEALTH INC (MEDS) stock pay dividends?

TRXADE HEALTH INC (MEDS) has a dividend yield of 125.16%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of MEDS dividend history, reliability and sustainability.

What is the Price/Earnings (PE) ratio of TRXADE HEALTH INC (MEDS)?

TRXADE HEALTH INC (MEDS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.29).

ChartMill assigns a fundamental rating of 3 / 10 to MEDS. The financial health of MEDS is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months MEDS reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS increased by 63.73% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to MEDS. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 4.1% for MEDS